Nan Shan Life Insurance’s West Pharmaceutical WST Stock Holding History

Nan Shan Life Insurance’s Portfolio WST Stock Details WST Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$11.2M	Sell	31,216 -78,651	-72%	-$24M	0.35%	60
2026 Q1	$27.5M	Hold	109,867	–	–	1%	36
2025 Q4	$30.2M	Hold	109,867	–	–	0.93%	32
2025 Q3	$28.8M	Sell	109,867 -413	-0.4%	-$100K	0.61%	54
2025 Q2	$24.1M	Sell	110,280 -1,557	-1%	-$333K	0.54%	61
2025 Q1	$25M	Sell	111,837 -3,973	-3%	-$1.09M	0.59%	57
2024 Q4	$37.9M	Buy	115,810 +29,800	+35%	+$9.38M	0.91%	40
2024 Q3	$25.8M	Buy	86,010 +76,010	+760%	+$23.3M	0.61%	54
2024 Q2	$3.29M	Buy	+10,000	New	+$3.53M	0.08%	93

Other funds holding WST

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM

Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM

Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

Artisan Partners Milwaukee, Wisconsin $63.1B AUM 35.51% 1-Year Est. Return

Bank of New York Mellon New York $609B AUM 40.19% 1-Year Est. Return

GIM

Generation Investment Management London, United Kingdom $10.3B AUM 4.84% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

T. Rowe Price Investment Management Baltimore, Maryland $153B AUM 38.14% 1-Year Est. Return

Nan Shan Life Insurance's WST Position: Q2 2026 in Review

Nan Shan Life Insurance reduced its West Pharmaceutical (WST) stake by 72% in Q2 2026, selling an estimated $24M and leaving 31,216 shares worth $11.2M. The position accounts for 0.35% of the portfolio, ranked #60.

Nan Shan Life Insurance first reported a position in WST in Q2 2024 and has held it in 9 quarters since. The position peaked at $37.9M in Q4 2024. 831 funds tracked by Wall St. Rank hold WST as of Q2 2026.

Nan Shan Life Insurance held 31,216 shares of West Pharmaceutical worth $11.2M as of Q2 2026.
Nan Shan Life Insurance sold 78,651 West Pharmaceutical shares in Q2 2026, an estimated $24M.
West Pharmaceutical made up 0.35% of Nan Shan Life Insurance's portfolio in Q2 2026, its #60 holding.
Nan Shan Life Insurance first reported a position in West Pharmaceutical in Q2 2024 and has held it in 9 quarters since.
Nan Shan Life Insurance's West Pharmaceutical position peaked at $37.9M in Q4 2024.
831 funds tracked by Wall St. Rank held West Pharmaceutical as of Q2 2026.

Based on Nan Shan Life Insurance's 13F filing for Q2 2026, filed 14 Aug 2026.